Netoglitazone

General description This gene encodes a member of the RING zinc finger protein family found in striated muscle and iris. The product of this gene is localized to the Z-line and M-line lattices of myofibrils, where titin&#8242:s N-terminal and

General description The UGTs (EC 2.4.

General description The vascular endothelial growth factor (VEGF) gene is localized on human chromosome 6p21.3 and is thought to encode four different isoforms.

Fibroblast Growth Factor 9 Recombinant Protein is suitable as a control for polyclonal or monoclonal anti-Fibroblast Growth Factor 9 in immunological assays.

The premade blots are prepared with the appropriate GenLysate and 50&mug protein is loaded onto a 4-20% denaturing polyacrylamide gel, along with a prestained molecular weight marker.&nbspAfter the proteins are resolved they are transferred to a

Size: 1 X 96-Well Strip Microplate Kit Target Name(s): TRANCE Accession Number: O35235 Gene Name(s): Tnfsf11, Opgl, Rankl, Trance Gene ID: 21943 Species Detected: Mouse Compatible Sample Types: Cell Culture Supernatants Plasma Serum Sensitivity: 4

A stable analogue of prostacyclin that potently and selectively activates the IP receptor (Ki = 20 nM) the active form of the prodrug NS-398 that is stable in vivo, as plasma concentrations of MRE-269 remain near peak levels for more than eight

A stable analogue of prostacyclin that potently and selectively activates the IP receptor (Ki = 20 nM) the active form of the prodrug NS-398 that is stable in vivo, as plasma concentrations of MRE-269 remain near peak levels for more than eight

A stable analogue of prostacyclin that potently and selectively activates the IP receptor (Ki = 20 nM) the active form of the prodrug NS-398 that is stable in vivo, as plasma concentrations of MRE-269 remain near peak levels for more than eight

A stable analogue of prostacyclin that potently and selectively activates the IP receptor (Ki = 20 nM) the active form of the prodrug NS-398 that is stable in vivo, as plasma concentrations of MRE-269 remain near peak levels for more than eight

Wnt/beta-catenin Inhibitors.

Wnt/beta-catenin Inhibitors.